Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Launay

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Vaccine|September 27, 2017
Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1-DiCo malaria vaccine adjuvanted with GLA-SE or Alhydrogel® in European and African adults: A phase 1a/1b, randomized, double-blind multi-centre trialS B Sirima, C Durier, L Kara, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 20, 2015
Vaccine coverage in CF children: A French multicenter studyA Masson, O Launay, B Delaisi, et al.
IJTLD Open|October 15, 2025
Management of latent TB infection: a national survey of French physiciansN Dournon, Y Tandjaoui-Lambiotte, C M Kilu, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 10, 2013
Persistence of yellow fever vaccine-induced antibodies after solid organ transplantationB Wyplosz, C Burdet, H François, et al.
Journal of Medical Economics|September 17, 2024
Cost-effectiveness and public health impact of using high dose quadrivalent influenza vaccine in the French older adults populationF P Alvarez, L Allard, F Bianic, et al.
The Journal of Antimicrobial Chemotherapy|June 4, 2011
Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavirT Bommenel, O Launay, J L Meynard, et al.
The Journal of Hospital Infection|February 26, 2013
Measles immunity and measles vaccine acceptance among healthcare workers in Paris, FranceR Freund, A Krivine, V Prévost, et al.
Journal of Immunological Methods|February 28, 2012
Pitfalls in anti-influenza T cell detection by Elispot using thimerosal containing pandemic H1N1 vaccine as antigenA Chauvat, N Benhamouda, E Loison, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 2, 2016
Clinical characteristics and outcome of respiratory syncytial virus infection among adults hospitalized with influenza-like illness in FranceP Loubet, N Lenzi, M Valette, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2004
Assessment of cetirizine, an antihistamine, to prevent cutaneous reactions to nevirapine therapy: results of the viramune-zyrtec double-blind, placebo-controlled trialO Launay, L Roudière, N Boukli, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Vaccine|September 27, 2017
Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1-DiCo malaria vaccine adjuvanted with GLA-SE or Alhydrogel® in European and African adults: A phase 1a/1b, randomized, double-blind multi-centre trialS B Sirima, C Durier, L Kara, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 20, 2015
Vaccine coverage in CF children: A French multicenter studyA Masson, O Launay, B Delaisi, et al.
IJTLD Open|October 15, 2025
Management of latent TB infection: a national survey of French physiciansN Dournon, Y Tandjaoui-Lambiotte, C M Kilu, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 10, 2013
Persistence of yellow fever vaccine-induced antibodies after solid organ transplantationB Wyplosz, C Burdet, H François, et al.
Journal of Medical Economics|September 17, 2024
Cost-effectiveness and public health impact of using high dose quadrivalent influenza vaccine in the French older adults populationF P Alvarez, L Allard, F Bianic, et al.
The Journal of Antimicrobial Chemotherapy|June 4, 2011
Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavirT Bommenel, O Launay, J L Meynard, et al.
The Journal of Hospital Infection|February 26, 2013
Measles immunity and measles vaccine acceptance among healthcare workers in Paris, FranceR Freund, A Krivine, V Prévost, et al.
Journal of Immunological Methods|February 28, 2012
Pitfalls in anti-influenza T cell detection by Elispot using thimerosal containing pandemic H1N1 vaccine as antigenA Chauvat, N Benhamouda, E Loison, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 2, 2016
Clinical characteristics and outcome of respiratory syncytial virus infection among adults hospitalized with influenza-like illness in FranceP Loubet, N Lenzi, M Valette, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2004
Assessment of cetirizine, an antihistamine, to prevent cutaneous reactions to nevirapine therapy: results of the viramune-zyrtec double-blind, placebo-controlled trialO Launay, L Roudière, N Boukli, et al.
Pageof 9